Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Ipo source : Www.biospace.com save search
Windtree Therapeutics Announces Reverse Stock Split - April 18, 2024
Published: 2024-04-18 (Crawled : 20:00) - biospace.com/
WINT | $0.3419 0.62% 0.61% 470K
|
Health Technology
|
| O: -30.25%
H: 0.0%
C: 0.0%
therapeutics
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - April 18, 2024
Published: 2024-04-18 (Crawled : 20:00) - biospace.com/
SDGR | $24.31 -0.12% -0.12% 600K
|
Technology Services
|
| O: 0.38%
H: 0.0%
C: 0.0%
nasdaq grants
Sunshine Biopharma Announces Reverse Stock Split
Published: 2024-04-12 (Crawled : 17:00) - biospace.com/
SBFM | News | $1.765 -46.84% -88.1% 11M
|
Professional, Scientific, and T...
|
| O: -2.41%
H: 0.0%
C: -5.76%
biopharma
Aptevo Therapeutics Announces Pricing of $4.6 Million Public Offering
Published: 2024-04-11 (Crawled : 20:00) - biospace.com/
APVO 4 d | $0.721 -6.36% -6.8% 230K
|
Health Technology
|
| O: -59.52%
H: 0.0%
C: 0.0%
million offering therapeutics
Leap Therapeutics Announces $40 Million Private Placement
Published: 2024-04-11 (Crawled : 20:00) - biospace.com/
LPTX | $2.81 -5.07% -5.34% 200K
|
Health Technology
|
| O: 15.13%
H: 25.43%
C: -11.0%
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: 0.5%
H: 0.83%
C: 0.28%
million leap therapeutics
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - April 10, 2024
Published: 2024-04-10 (Crawled : 12:00) - biospace.com/
BBIO | $24.74 -0.84% -0.85% 2M
|
Health Technology
|
| O: -4.11%
H: 0.81%
C: 0.15%
pharma nasdaq grants
Jaguar Health Granted Extension Until August 13, 2024, to Regain Compliance with Nasdaq's Bid Price Requirement
Published: 2024-04-08 (Crawled : 14:00) - biospace.com/
JAGX | $0.158 -10.79% -12.09% 30M
|
Health Technology
|
| O: 7.14%
H: 1.11%
C: -8.89%
health granted extension
TRACON Pharmaceuticals Announces Reverse Stock Split - April 8, 2024
Published: 2024-04-08 (Crawled : 14:00) - biospace.com/
TCON | $1.97 -6.64% -7.11% 240K
|
Health Technology
|
| O: -3.97%
H: 0.0%
C: -20.69%
pharmaceuticals
Biodesix Announces Pricing of Oversubscribed and Upsized Underwritten Offering of Common Stock and Concurrent Private Placement
Published: 2024-04-05 (Crawled : 13:30) - biospace.com/
BDSX | $1.24 -0.8% -0.81% 48K
|
Health Services
|
| O: -13.25%
H: 14.5%
C: 6.87%
offering
StageZero Life Sciences Provides an Update on Application for Management Cease Trade Order
Published: 2024-04-05 (Crawled : 13:30) - biospace.com/
SZLSF | $0.039 -11.46% 950
|
n/a
| Email alert
Add to watchlist
management life update sciences for order application
Equillium Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Published: 2024-04-03 (Crawled : 13:30) - biospace.com/
EQ | $1.63 -5.78% -6.13% 100K
|
Health Technology
|
| O: -0.92%
H: 11.57%
C: 7.87%
nasdaq grant
Melt Pharmaceuticals Closes $24 Million Series B Preferred Stock Financing
Published: 2024-04-02 (Crawled : 15:30) - biospace.com/
HROW P 29400 | $10.43 -3.87% -4.03% 680K
|
Health Technology
|
| O: -2.11%
H: 0.96%
C: -1.2%
million series pharmaceuticals
Sangamo Therapeutics Announces Pricing of $24.0 Million Registered Direct Offering
Published: 2024-03-22 (Crawled : 13:00) - biospace.com/
SGMO | $0.5143 6.02% 5.68% 1M
|
Health Technology
|
| O: -5.18%
H: 0.54%
C: -23.59%
million direct offering therapeutics
Delcath Systems Closes $7 Million Private Placement
Published: 2024-03-20 (Crawled : 13:00) - biospace.com/
DCTH | $4.87 3.73% 3.59% 300K
|
Health Technology
|
| O: 0.23%
H: 4.66%
C: -0.93%
million
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - March 19, 2024
Published: 2024-03-19 (Crawled : 17:00) - biospace.com/
SDGR | $24.31 -0.12% -0.12% 600K
|
Technology Services
|
| O: -1.48%
H: 3.64%
C: 2.92%
nasdaq grants
Fusion Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - March 6, 2024
Published: 2024-03-06 (Crawled : 17:00) - biospace.com/
FUSN | $21.26 0.05% 0.05% 440K
|
Health Technology
|
| O: 1.33%
H: 2.16%
C: -6.95%
nasdaq pharmaceuticals grants
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - March 5, 2024
Published: 2024-03-05 (Crawled : 14:30) - biospace.com/
INSM | $24.4 -1.61% -1.64% 5.5M
|
Health Technology
|
| O: -0.57%
H: 1.46%
C: -1.03%
nasdaq grants
Revance Announces Pricing of $100.0 Million Public Offering of Common Stock
Published: 2024-03-04 (Crawled : 17:00) - biospace.com/
VTRS A | $11.25 1.17% 1.16% 4.7M
|
Health Technology
|
| O: 0.0%
H: 0.08%
C: -1.83%
RVNC | $3.77 -0.53% -0.53% 1.6M
|
Health Technology
|
| O: -11.6%
H: 3.89%
C: -1.62%
million offering
Nektar Therapeutics Announces $30 Million Private Placement Financing with TCGX
Published: 2024-03-04 (Crawled : 14:30) - biospace.com/
NKTR | News | $1.265 -4.17% -4.35% 4.7M
|
Health Technology
|
| O: 23.08%
H: 12.5%
C: -6.25%
million therapeutics
Aptevo Therapeutics Announces 1-for 44 Reverse Stock Split As Part of Nasdaq Compliance Plan
Published: 2024-03-04 (Crawled : 14:30) - biospace.com/
APVO 4 d | $0.721 -6.36% -6.8% 230K
|
Health Technology
|
| O: -9.76%
H: 4.59%
C: -4.39%
nasdaq therapeutics
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.